Pediatric combination vaccines: Their impact on patients, providers, managed care organizations, and manufacturers

American Journal of Managed Care

Volumn 9, Issue 4, 2003, Pages 314-320

  Marcy, S Michael ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER FOUNDATION HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ANTIGEN FUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECONOMIC ASPECT; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; LABORATORY TEST; MANAGED CARE ORGANIZATION; MEDICAL RESEARCH; PARALYSIS; PEDIATRICS; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; SIDE EFFECT; SOCIAL ASPECT; TREATMENT PLANNING;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DRUG EVALUATION; DRUG INDUSTRY; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MANAGED CARE PROGRAMS; PARENTS; PEDIATRICS; SAFETY; TREATMENT OUTCOME; UNITED STATES; VACCINES, COMBINED;

EID: 0037741883     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Peter D, ed. 1991 Red Book: Report of the Committee on Infectious Diseases. 22nd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1991.
2. Centers for Disease Control and Prevention. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR Morb Mortal Wkly Rep. 2002;51(RR-2):1-35.
3. Parkman PD. Combined and simultaneously administered vaccines: A brief history. Ann N Y Acad Sci. 1995;754:1-9.
4. Schmitt H-J, Knuf M, Ortiz E, et al. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J. Pediatr. 2000;137:304-312.
5. Lessel L, Vose J. Combination vaccines [letter]. J Pediatr. 2001;138:613.
6. Centers for Disease Control and Prevention. Combination vaccines for childhood immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR Morb Mortal Wkly Rep. 1999;48(RR-5):1-15.
7. Decker MD, Edwards KM. Combination vaccines: Problems and promise [editorial]. J Pediatr. 2000;137:291-295.
8. Halsey NA. Combination vaccines: Defining and addressing current safety concerns. Clin Infect Dis. 2001;33(suppl 4):S312-S318.
9. Breiman, R, Goldenthal K, eds. International Symposium on Combination Vaccines: Proceedings of a Symposium Organized and Sponsored by the National Vaccine Program and Held at the National Institutes of Health, February 2-4, 2000. Clin Infect Dis. 2001;33(suppl 4):S261-S375.
10. Dagan R, Botujansky C, Watemberg N, et al. Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J. 1994;13:356-361.
11. Mulholland EK, Ahonkhai VI, Greenwood AM, et al. Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Pediatr Infect Dis J. 1993;12:632-637.
12. Halsey NA, Blatter M, Bader G, et al. Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in 2-, 4-, and 6-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine. Pediatr Infect Dis J. 1997;16:675-769.
13. Robbins A. The Children's Vaccine Initiative. Am J Dis Child. 1993;147:152-153.
14. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev. 2001;14:430-445.
15. Centers for Disease Control and Prevention. Vaccine Identification Standards Initiative. Available at: http:www.cdc.gov/nip/visi. Accessed December 13, 2002. 20002.
16. Dagan R, Eskola J, Leclerc C, et al. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immunol. 1998;66:2093-2098.
17. Parkman PD, Hardegree MC. Regulation and testing of vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1999;1131-1144.
18. Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann N Y Acad Sci. 1995;754:35-47.
19. Decker MD, Edwards KM. Combination vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders Co; 1999;519-530.
20. Granoff DM. Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clin Infect Dis. 2001;33(supp 4):S278-S287.
21. Schmitt H-J, VonKries R, Hassenpflug B, et al. Haemophilus influenzae type b disease: Impact and effectiveness of diphtheria-tetanus-acellular pertussis (-inactivated poliovirus)/H influenzae type b combination vaccines. Pediatr Infect Dis J. 2001;20:767-774.
22. Fritzell B. Definition and clinical assessment of consistency lots for combination vaccines. Ann N Y Acad Sci. 1995;754:83-88.
23. McClintock DK. Combination vaccines: Regulatory issues. Ann N Y Acad Sci. 1995;754:27-34.
24. Edwards KM, Decker MD. Combination vaccines consisting of acellular pertussis vaccines. Pediatr Infect Dis J. 1997;16:597-102.
25. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J. 2001;20:63-75.
26. Chen RT. Safety of vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1999:1144-1163.
27. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572.
28. Robbins FC, Mortimer EA Jr. Vaccine licensure: A proposal to meet changing needs. Ann N Y Acad Sci. 1995;754:368-376.
29. Chen RT, Glasser J, Rhodes P, et al. The Vaccine Safety Datalink Project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99:765-773.
30. Chen RT, Pool V, Takahashi H, et al. Combination vaccines: Postlicensure safety evaluation. Clin Infect Dis. 2001;33(suppl 4):S327-S333.
31. Woodin KA, Rodewald LE, Humiston SG, et al. Physician and parent opinions: Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med. 1995;149:845-849.
32. Melman ST, Chawla T, Kaplan JM, et al. Multiple immunizations: Ouch! Arch Fam Med. 1994;3:615-618.
33. Halperin BA, Eastwood BJ, Halperin SA. Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine. Pediatr Infect Dis J. 1998;17:103-110.
34. Szilagyi PG, Rodewald LE, Humiston SG, et al. Immunization practices of pediatricians and family physicians in the United States. Pediatrics. 1994;94:517-523.
35. Lieu TA, Black SB, Ray GT, et al. The hidden costs of infant vaccination. Vaccine. 2001;19:33-41.
36. Meyerhoff AS, Weniger BG, Jacogs RJ. Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatr Infect Dis J. 2001;20:S57-S62.
37. Madlon-Kay DJ, Harper PG. Too many shots? Parent, nurse, and physician attitudes toward multiple simultaneous childhood vaccinations. Arch Fam Med. 1994;3:610-613.
38. Lieu T, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000;283:1460-1468.
39. Ray GT, Butler JC, Black SB, et al. Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002;21:361-365.
40. Hadler SC. Cost benefit of combining antigens. Biologicals. 1994;22:4315-4418.
41. Miller MA, Hinman AR. Cost-benefit and cost effectiveness analysis of vaccine policy. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1999;1074-1088.
42. France EK, Nugent EW. Impact of combination vaccines on immunization administration: Time and motion study. Paper presented at: Pediatric Academic Societies Annual Meeting; April 28-May 1, 2002; Baltimore, Md.
43. Pellisier JM, Coplan PM, Jackson LA, et al. The effect of additional shots on the vaccine administration process: Results of a time-motion study in 2 settings. Am J Manag Care. 2000;6:1038-1044.
44. Anthony BF. FDA perspective on regulatory issues in vaccine development. Ann N Y Acad Sci. 1995;754:10-16.
45. Sewell ED, Jacobson S, Weniger BG. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr Infect Dis J. 2001;20:S45-S56.
46. Dietz VJ, Steveson J, Zell ER, et al. Potential impact on vaccination levels by administering vaccines simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med. 1994;148:943-948.
47. Ball TM, Serwint JR. Missed opportunities for vaccination and the delivery of preventive care. Arch Pediatr Adolesc Med. 1996;150:858-861.